Drugs / EnteroMix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07584668 | Jul 2025 → Dec 2026 expected | — | National Medical Research Radiological Centre of the Ministry of Health of Russia | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EnteroMix | “EnteroMix will be administered once at three dose levels:” NCT07584668 ↗ |
| Modality | Other / unclassified | “Enterovirus-based EM-I-2024” NCT07584668 ↗ |
| Route | Intravenous | “EnteroMix will be administered intravenously.” NCT07584668 ↗ |